Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 13, 2025 04:18 ET | Source: Research and Markets

Non-Alcoholic Steatohepatitis (NASH) Pipeline Insight Report, 2025 - Featuring Analysis of Inventiva Pharma, Cirius Therapeutics, Terns Pharmaceuticals, HighTide Biopharma, Eli Lilly and Company, and More

Dublin, May 13, 2025 (GLOBE NEWSWIRE) -- The "Non-Alcoholic Steatohepatitis (NASH) - Pipeline Insight, 2025" clinical trials has been added to ResearchAndMarkets.com's offering.This report provides...
May 02, 2024 07:25 ET | Source: Research and Markets

Non-Alcoholic Steatohepatitis (NASH) Pipeline Insight, 2024 Featuring 100+ Companies and 110+ Pipeline Drugs Including Lanifibranor (Inventiva Pharma), MSDC-0602K (Cirius Therapeutics), TERN-501 (Terns Pharma)

Dublin, May 02, 2024 (GLOBE NEWSWIRE) -- The "Non-Alcoholic Steatohepatitis (NASH) - Pipeline Insight, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.This report provides...
January 30, 2024 07:09 ET | Source: Research and Markets

Japan Non-Alcoholic Steatohepatitis (NASH) Market Forecast 2023-2032: Emerging Therapies & Treatment Insights, Comprehensive Market Outlook, Expert & Qualitative Analyses

Dublin, Jan. 30, 2024 (GLOBE NEWSWIRE) -- The "Japan Non-Alcoholic Steatohepatitis (NASH) - Market Insights, Epidemiology and Market Forecast - 2032" report has been added to ...
March 23, 2021 08:08 ET | Source: Research and Markets

Global Non-alcoholic Steatohepatitis (NASH) Market 2021-2038: Increased Competition from New Product Launches will Shape the NASH Market

Dublin, March 23, 2021 (GLOBE NEWSWIRE) -- The "Non-alcoholic steatohepatitis (NASH) Market and Forecast Analysis to 2038" report has been added to ResearchAndMarkets.com's offering. There are...